It is estimated that around a third of cancer patients die because of cachexia - a syndrome characterized by muscle-wasting, weight loss, and metabolic changes that cannot be treated just by increasing food intake. Now, researchers have compiled a diagnostic tool comprising readily available measures and tests that could potentially extend survival in advanced cancer patients by helping to diagnose cachexia in its early stages - before it becomes irreversible.
